breseq  version 0.33.1  revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log

Marginal read alignment evidence
  seq id position ref new freq score (cons/poly) reads annotation genes product
*USA300TCH1516_ALE512,6430AG45.4% 62.8 / 295.3 218intergenic (+711/‑6052)recR/speA_2Recombination protein RecR/Arginine decarboxylase
*USA300TCH1516_ALE111,5160CA35.9% 254.5 / 165.4 170Q196K (CAA→AAA) USA300HOU_RS00520putative lipoprotein
*USA300TCH1516_ALE111,5120AG35.6% 195.0 / 179.0 175S194S (TCA→TCGUSA300HOU_RS00520putative lipoprotein

Marginal new junction evidence (lowest skew 10 of 123 shown)
  seq id position reads (cov) reads (cov) score skew freq annotation gene product
* ? USA300TCH1516_ALE = 120532393 (0.820)44 (0.530)
+38 bp
10/200 11.3 38.6% intergenic (‑204/‑365) USA300HOU_RS15290/lspA hypothetical protein/Lipoprotein signal peptidase
?USA300TCH1516_ALE 2478252 = 100 (0.880)intergenic (+139/‑436) USA300HOU_RS12760/USA300HOU_RS12765 hypothetical protein/hypothetical protein
* ? USA300TCH1516_ALE = 120532393 (0.820)44 (0.530)
+38 bp
10/200 11.3 38.5% intergenic (‑204/‑365) USA300HOU_RS15290/lspA hypothetical protein/Lipoprotein signal peptidase
?USA300TCH1516_ALE = 2072043 101 (0.890)intergenic (+538/+35) USA300HOU_RS10445/USA300HOU_RS10450 hypothetical protein/hypothetical protein
* ? USA300TCH1516_ALE = 120532393 (0.820)44 (0.530)
+38 bp
10/200 11.3 39.5% intergenic (‑204/‑365) USA300HOU_RS15290/lspA hypothetical protein/Lipoprotein signal peptidase
?USA300TCH1516_ALE = 1443739 NA (NA)intergenic (‑312/+41) USA300TCH1516_01342/brnQ_3 hypothetical protein/Branched‑chain amino acid transport system 2 carrier protein
* ? USA300TCH1516_ALE = 120532393 (0.820)44 (0.530)
+38 bp
10/200 11.3 39.5% intergenic (‑204/‑365) USA300HOU_RS15290/lspA hypothetical protein/Lipoprotein signal peptidase
?USA300TCH1516_ALE 1426517 = 93 (0.820)intergenic (‑248/+724) pstS/cvfB Phosphate‑binding protein PstS/Conserved virulence factor B
* ? USA300TCH1516_ALE = 2609406107 (0.940)9 (0.090) 8/252 15.6 8.7% intergenic (‑236/+325) USA300HOU_RS13450/USA300HOU_RS13455 hypothetical protein/putative lipoprotein
?USA300TCH1516_ALE = 2609438 92 (0.880)intergenic (‑268/+293) USA300HOU_RS13450/USA300HOU_RS13455 hypothetical protein/putative lipoprotein
* ? USA300TCH1516_ALE 1205383 =105 (0.920)27 (0.290)
+25 bp
6/226 15.6 30.1% intergenic (‑264/‑305) USA300HOU_RS15290/lspA hypothetical protein/Lipoprotein signal peptidase
?USA300TCH1516_ALE 2478476 = 48 (0.420)intergenic (+363/‑212) USA300HOU_RS12760/USA300HOU_RS12765 hypothetical protein/hypothetical protein
* ? USA300TCH1516_ALE 1205383 =105 (0.920)32 (0.340)
+25 bp
6/226 15.6 34.9% intergenic (‑264/‑305) USA300HOU_RS15290/lspA hypothetical protein/Lipoprotein signal peptidase
?USA300TCH1516_ALE 1426741 = 41 (0.360)intergenic (‑472/+500) pstS/cvfB Phosphate‑binding protein PstS/Conserved virulence factor B
* ? USA300TCH1516_ALE 329202 =135 (1.180)8 (0.080) 8/256 15.8 6.2% intergenic (+70/+73) USA300HOU_RS01475/ssaA2_1 hypothetical protein/Staphylococcal secretory antigen ssaA2
?USA300TCH1516_ALE 329255 = 117 (1.110)intergenic (+123/+20) USA300HOU_RS01475/ssaA2_1 hypothetical protein/Staphylococcal secretory antigen ssaA2
* ? USA300TCH1516_ALE = 234750124 (1.090)9 (0.090) 8/256 15.8 7.0% intergenic (+48/+217) USA300HOU_RS01045/gsiA hypothetical protein/Glutathione import ATP‑binding protein GsiA
?USA300TCH1516_ALE = 234763 123 (1.160)intergenic (+61/+204) USA300HOU_RS01045/gsiA hypothetical protein/Glutathione import ATP‑binding protein GsiA
* ? USA300TCH1516_ALE = 195477795 (0.830)8 (0.080) 7/254 16.4 8.4% intergenic (‑39/+26) nisB/gdmA Nisin biosynthesis protein NisB/Lantibiotic gallidermin
?USA300TCH1516_ALE = 1954783 87 (0.830)intergenic (‑45/+20) nisB/gdmA Nisin biosynthesis protein NisB/Lantibiotic gallidermin